Systemic osteoprotective effects of Epimedii Folium and Ligustri Lucidi Fructus in senile osteoporosis rats by promoting the osteoblastogenesis and osteoclastogenesis based on MLP-ANN model.
Source check: Source checked. Not independent scientific confirmation.
Finding: The study reports bone outcomes and osteoblast/osteoclast markers in treated rats, with model analyses linking herbal components to measured effects. Rat-model findings do not establish efficacy or safety in people; the computational component analysis is not causal proof of each component’s mechanism.
Technology: An MLP artificial neural network analyzed herb-component relationships alongside animal experiments on Epimedii Folium and Ligustri Lucidi Fructus in senile osteoporosis rats.
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- An MLP artificial neural network analyzed herb-component relationships alongside animal experiments on Epimedii Folium and Ligustri Lucidi Fructus in senile osteoporosis rats.
- Test and result
- The study reports bone outcomes and osteoblast/osteoclast markers in treated rats, with model analyses linking herbal components to measured effects.
- Limitation / still unknown
- Rat-model findings do not establish efficacy or safety in people; the computational component analysis is not causal proof of each component’s mechanism.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC7441627/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.